Literature DB >> 33174221

Genotype FBN1/phenotype relationship in a cohort of patients with Marfan syndrome.

Amparo Hernándiz1, Angel Zúñiga2, Francisco Valera3, Diana Domingo4, Imelda Ontoria-Oviedo1, Jose F Marí5, Jose A Román6, Inmaculada Calvo7, Beatriz Insa8, Rosa Gómez9, José V Cervera2, Manuel Miralles10, Jose A Montero1, Luis Martínez-Dolz4,11, Pilar Sepúlveda1,11.   

Abstract

Marfan syndrome (MFS) is a systemic connective tissue disorder caused by mutations in the fibrillin-1 (FBN1) gene, and cardiovascular involvement is the leading cause of mortality. We sought to examine the genotype/phenotype realtionship in 61 consecutive patients with a phenotype and genotype compatible with MFS. The FBN1 gene was analyzed by massive sequencing using a hybridization capture-based target enrichment custom panel. Forty-three different variants of FBN1 were identified, of which 17 have not been previously reported. The causal variants of MFS were grouped into mutations resulting in haploinsufficiency (HI group; 23 patients) and mutations producing a dominant-negative effect (DN group; 38 patients). Patient information was collected from electronic medical records and clinical evaluation. While no significant differences were found between the two groups, the HI group included more cases with aortic dissection and occurring at a younger age that the DN group (34.7% vs. 15.8%; p = 0.160). Irrespective of the mutation group, males presented with a higher probability of aortic involvement (4-fold higher risk than females) and aortic dissections events occurred at younger ages. Patients with DN variants carrying a cysteine substitution had a higher incidence of ectopia lentis.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FBN1; Marfan syndrome; aortic dissection; gender

Year:  2020        PMID: 33174221     DOI: 10.1111/cge.13879

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Fibroblast-Secreted Phosphoprotein 1 Mediates Extracellular Matrix Deposition and Inhibits Smooth Muscle Cell Contractility in Marfan Syndrome Aortic Aneurysm.

Authors:  Mei Zhou; Yuexin Zhu; Zeyi Zhou; Feiran Qi; Shuai Zheng; Shijuan Gao; Yulin Li; Yan Liu; Jie Du
Journal:  J Cardiovasc Transl Res       Date:  2022-04-12       Impact factor: 4.132

Review 2.  Potential predictors of severe cardiovascular involvement in Marfan syndrome: the emphasized role of genotype-phenotype correlations in improving risk stratification-a literature review.

Authors:  Zoltán Szabolcs; Kálmán Benke; Roland Stengl; Bence Ágg; Miklós Pólos; Gábor Mátyás; Gábor Szabó; Béla Merkely; Tamás Radovits
Journal:  Orphanet J Rare Dis       Date:  2021-05-31       Impact factor: 4.123

Review 3.  Translational Medicine: Towards Gene Therapy of Marfan Syndrome.

Authors:  Klaus Kallenbach; Anca Remes; Oliver J Müller; Rawa Arif; Marcin Zaradzki; Andreas H Wagner
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.